Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice

Mario Nuvolone; Giampaolo Merlini

doi:10.1016/j.kint.2018.11.003

Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice

Mario Nuvolone, Giampaolo Merlini

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Effective therapies for Ig light chain (AL) amyloidosis has led to an increasing proportion of patients with end-stage renal disease requiring renal replacement therapy, yet kidney transplantation is seldom performed in this setting due to concerns of renal and extrarenal disease progression. Angel-Korman et al. report unprecedented positive long-term outcomes in the largest series of kidney transplantation in AL amyloidosis providing the basis for a more proactive approach to this procedure.

Original language	English
Pages (from-to)	258-260
Number of pages	3
Journal	Kidney International
Volume	95
Issue number	2
DOIs	https://doi.org/10.1016/j.kint.2018.11.003
Publication status	Published - Feb 1 2019

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.kint.2018.11.003

Fingerprint Dive into the research topics of 'Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice'. Together they form a unique fingerprint.

Cite this

@article{f850cede7a164ba99f4eb6ca383df051,

title = "Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice",

abstract = "Effective therapies for Ig light chain (AL) amyloidosis has led to an increasing proportion of patients with end-stage renal disease requiring renal replacement therapy, yet kidney transplantation is seldom performed in this setting due to concerns of renal and extrarenal disease progression. Angel-Korman et al. report unprecedented positive long-term outcomes in the largest series of kidney transplantation in AL amyloidosis providing the basis for a more proactive approach to this procedure.",

author = "Mario Nuvolone and Giampaolo Merlini",

year = "2019",

month = feb,

day = "1",

doi = "10.1016/j.kint.2018.11.003",

language = "English",

volume = "95",

pages = "258--260",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Improved outcomes for kidney transplantation in AL amyloidosis

T2 - impact on practice

AU - Nuvolone, Mario

AU - Merlini, Giampaolo

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Effective therapies for Ig light chain (AL) amyloidosis has led to an increasing proportion of patients with end-stage renal disease requiring renal replacement therapy, yet kidney transplantation is seldom performed in this setting due to concerns of renal and extrarenal disease progression. Angel-Korman et al. report unprecedented positive long-term outcomes in the largest series of kidney transplantation in AL amyloidosis providing the basis for a more proactive approach to this procedure.

AB - Effective therapies for Ig light chain (AL) amyloidosis has led to an increasing proportion of patients with end-stage renal disease requiring renal replacement therapy, yet kidney transplantation is seldom performed in this setting due to concerns of renal and extrarenal disease progression. Angel-Korman et al. report unprecedented positive long-term outcomes in the largest series of kidney transplantation in AL amyloidosis providing the basis for a more proactive approach to this procedure.

UR - http://www.scopus.com/inward/record.url?scp=85059854532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059854532&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2018.11.003

DO - 10.1016/j.kint.2018.11.003

M3 - Comment/debate

AN - SCOPUS:85059854532

VL - 95

SP - 258

EP - 260

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -